Trial intelligence / Profile preview

Oral Ketorolac for Postoperative Pain in Rotator Cuff Repair

NCT03967847Phase 3Completed

Sponsor
University Hospitals Cleveland Medical Center
Start
Feb 2019
Primary completion
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of ketorolac in postoperative pain (2 arms), sponsored by University Hospitals Cleveland Medical Center. Primary endpoint: Postoperative Visual Analog Scale Scores up to 8 weeks. Started Feb 2019; status: completed.

02

Drugs

ketorolac
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03967847.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03967847.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call